Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second‐trimester using chromosomal microarray analysis
Birth Defects Research · 2024
DOI: 10.1002/bdr2.2351 ↗Kurz gefasst
Fachartikel in der Zeitschrift Birth Defects Research, 2024. Verfasst von Xinying Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Nasal Bone, Microarray Analysis, Pregnancy Trimester, Second, Prenatal Diagnosis. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Fujian Provincial Health Technology Project, Joint Funds for the Innovation of Science and Technology, Fujian Province, Fujian Provincial Science and Technology Project.
Abstract (Originalsprache)
Background
Pathogenic copy number variants (pCNVs) are associated with fetal ultrasound anomalies, which can be efficiently identified through chromosomal microarray analysis (CMA). The primary objective of the present study was to enhance understanding of the genotype–phenotype correlation in fetuses exhibiting absent or hypoplastic nasal bones using CMA.
Methods
Enrolled in the present study were 94 cases of fetuses with absent/hypoplastic nasal bone, which were divided into an isolated absent/hypoplastic nasal bone group ( n = 49) and a non‐isolated group ( n = 45). All pregnant women enrolled in the study underwent karyotype analysis and CMA to assess chromosomal abnormalities in the fetuses.
Results
Karyotype analysis and CMA detection were successfully performed in all cases. The results of karyotype and CMA indicate the presence of 11 cases of chromosome aneuploidy, with trisomy 21 being the most prevalent among them. A small supernumerary marker chromosome (sSMC) detected by karyotype analysis was further interpreted as a pCNV by CMA. Additionally, CMA detection elicited three cases of pCNVs, despite normal findings in their karyotype analysis results. Among them, one case of Roche translocation was identified to be a UPD in chromosome 15 with a low proportion of trisomy 15. Further, a significant difference in the detection rate of pCNVs was observed between non‐isolated and isolated absent/hypoplastic nasal bone (24.44% vs. 8.16%, p < .05).
Conclusion
The present study enhances the utility of CMA in diagnosing the etiology of absent or hypoplastic nasal bone in fetuses. Further, isolated cases of absent or hypoplastic nasal bone strongly suggest the presence of chromosomal abnormalities, necessitating genetic evaluation through CMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Fujian Medical University, Fuzhou, China.
- Prenatal Diagnosis Center, Quanzhou Women's and Children's Hospital, Quanzhou, China.
- Medical Genetic Diagnosis and Therapy Center, Fujian Maternity and Child Health Hospital, College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fujian Provincial Key Laborat…
ORCID-Profile: Jianlong Zhuang
Förderung
- Fujian Provincial Health Technology Project
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Fujian Provincial Science and Technology Project
- The Key Project on the Integration of Industry, Education and Research Collaborative Innovation of Fujian Province
- The Key Project on Science and Technology Program of Fujian Health Commission
Zitieren
APA
Chen, X., Jiang, Y., Zeng, S., Zhuang, J., & Lin, N. (2024). Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second‐trimester using chromosomal microarray analysis. Birth Defects Research. https://doi.org/10.1002/bdr2.2351
Vancouver
Chen X, Jiang Y, Zeng S, Zhuang J, Lin N. Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second‐trimester using chromosomal microarray analysis. Birth Defects Research. 2024. doi:10.1002/bdr2.2351
BibTeX
@article{Chen2024,
author = {Chen, Xinying and Jiang, Yuying and Zeng, Shuhong and Zhuang, Jianlong and Lin, Na},
title = {Prenatal diagnosis of fetuses with absent/hypoplastic nasal bone in second‐trimester using chromosomal microarray analysis},
journal = {Birth Defects Research},
year = {2024},
doi = {10.1002/bdr2.2351}
}
EUVIMED